KOSDAQ records 10 times higher growth rate in export than KOSPI
It was observed the KOSDAQ listed pharmaceutical companies’ average foreign sales & export ratio of this 1st quarter was twice higher than the one of the KOSPI. The KOSDAQ’s growth rate was more than 10 times higher than the KOSPI’s one.
According to the Yakup Shinmoon’s(www.yakup.com) analysis ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
